Results 291 to 300 of about 5,919,627 (334)
Some of the next articles are maybe not open access.
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.
Journal of the American Medical Association (JAMA), 2021Importance Colorectal cancer is the third leading cause of cancer death for both men and women, with an estimated 52 980 persons in the US projected to die of colorectal cancer in 2021. Colorectal cancer is most frequently diagnosed among persons aged 65
K. Davidson +17 more
semanticscholar +1 more source
The Lancet, 2014
More than 1·2 million patients are diagnosed with colorectal cancer every year, and more than 600,000 die from the disease. Incidence strongly varies globally and is closely linked to elements of a so-called western lifestyle. Incidence is higher in men than women and strongly increases with age; median age at diagnosis is about 70 years in developed ...
Hermann, Brenner +2 more
openaire +3 more sources
More than 1·2 million patients are diagnosed with colorectal cancer every year, and more than 600,000 die from the disease. Incidence strongly varies globally and is closely linked to elements of a so-called western lifestyle. Incidence is higher in men than women and strongly increases with age; median age at diagnosis is about 70 years in developed ...
Hermann, Brenner +2 more
openaire +3 more sources
Clinical Oncology, 2016
Essential facts Colorectal cancer is the fourth most common cancer in the UK, after breast, lung and prostate cancer, with around 41,600 people in the UK diagnosed each year. It is the second most common cause of cancer death in the UK. According to the charity Bowel Cancer UK, 98% of people diagnosed at the earliest stage will survive, while less than
D C, Gilbert, S J, Falk
openaire +4 more sources
Essential facts Colorectal cancer is the fourth most common cancer in the UK, after breast, lung and prostate cancer, with around 41,600 people in the UK diagnosed each year. It is the second most common cause of cancer death in the UK. According to the charity Bowel Cancer UK, 98% of people diagnosed at the earliest stage will survive, while less than
D C, Gilbert, S J, Falk
openaire +4 more sources
The Lancet, 2010
Substantial progress has been made in colorectal cancer in the past decade. Screening, used to identify individuals at an early stage, has improved outcome. There is greater understanding of the genetic basis of inherited colorectal cancer and identification of patients at risk.
David, Cunningham +6 more
openaire +2 more sources
Substantial progress has been made in colorectal cancer in the past decade. Screening, used to identify individuals at an early stage, has improved outcome. There is greater understanding of the genetic basis of inherited colorectal cancer and identification of patients at risk.
David, Cunningham +6 more
openaire +2 more sources
The Lancet Gastroenterology and Hepatology, 2022
The incidence of early-onset colorectal-ie, colorectal cancer cancer diagnosed in patients under the age of 50 years- has been increasing around the world.
Swati G. Patel +4 more
semanticscholar +1 more source
The incidence of early-onset colorectal-ie, colorectal cancer cancer diagnosed in patients under the age of 50 years- has been increasing around the world.
Swati G. Patel +4 more
semanticscholar +1 more source
The Lancet Oncology, 2021
BACKGROUND Colorectal cancer screening programmes and uptake vary substantially across Europe. We aimed to compare changes over time in colorectal cancer incidence, mortality, and stage distribution in relation to colorectal cancer screening ...
R. Cardoso +55 more
semanticscholar +1 more source
BACKGROUND Colorectal cancer screening programmes and uptake vary substantially across Europe. We aimed to compare changes over time in colorectal cancer incidence, mortality, and stage distribution in relation to colorectal cancer screening ...
R. Cardoso +55 more
semanticscholar +1 more source
Hematology/Oncology Clinics of North America, 2022
Around 10% to 16% of colorectal cancer patients have a pathogenic variant in a cancer susceptibility gene. Some of these variants are in cancer genes that are associated with colorectal cancer while others are not. The hereditary colorectal cancer syndromes can be divided into two major categories, the nonpolyposis and the polyposis conditions.
Heather, Hampel +3 more
openaire +2 more sources
Around 10% to 16% of colorectal cancer patients have a pathogenic variant in a cancer susceptibility gene. Some of these variants are in cancer genes that are associated with colorectal cancer while others are not. The hereditary colorectal cancer syndromes can be divided into two major categories, the nonpolyposis and the polyposis conditions.
Heather, Hampel +3 more
openaire +2 more sources
The Lancet, 2005
Every year, more than 945000 people develop colorectal cancer worldwide, and around 492000 patients die. This form of cancer develops sporadically, in the setting of hereditary cancer syndromes, or on the basis of inflammatory bowel diseases. Screening and prevention programmes are available for all these causes and should be more widely publicised ...
Jürgen, Weitz +5 more
openaire +4 more sources
Every year, more than 945000 people develop colorectal cancer worldwide, and around 492000 patients die. This form of cancer develops sporadically, in the setting of hereditary cancer syndromes, or on the basis of inflammatory bowel diseases. Screening and prevention programmes are available for all these causes and should be more widely publicised ...
Jürgen, Weitz +5 more
openaire +4 more sources
A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.
New England Journal of MedicineBACKGROUND Colorectal cancer is the third most diagnosed cancer in adults in the United States. Early detection could prevent more than 90% of colorectal cancer-related deaths, yet more than one third of the screening-eligible population is not up to ...
Daniel C. Chung +12 more
semanticscholar +1 more source
The Lancet
Despite decreased incidence rates in average-age onset patients in high-income economies, colorectal cancer is the third most diagnosed cancer in the world, with increasing rates in emerging economies. Furthermore, early onset colorectal cancer (age ≤50 years) is of increasing concern globally.
Eng, Cathy +8 more
openaire +2 more sources
Despite decreased incidence rates in average-age onset patients in high-income economies, colorectal cancer is the third most diagnosed cancer in the world, with increasing rates in emerging economies. Furthermore, early onset colorectal cancer (age ≤50 years) is of increasing concern globally.
Eng, Cathy +8 more
openaire +2 more sources